A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ASC35 Injection in Participants With Obesity or Overweight

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
This randomized, double-blind, placebo-controlled single ascending dose (SAD)/ multiple ascending dose (MAD) study is designed to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of ASC35 injection
Epistemonikos ID: 31d8634a900e4f9ac12ee128ea85b3e6567ac1c8
First added on: Sep 26, 2026